Conferences - Seminars

Cancelled Thumbnail
  Monday 26 February 2018 17:00 - 18:00 BCH 5310

Fusion and connection of classical and new chemical modalities for ‘undruggable’ targets

By Dr. Eric Valeur, AstraZeneca

Eric Valeur is Associate Director for New Modalities at AstraZeneca. He is driving research within the chemical space at the interface of small and large molecules. His present research interests include small molecules, peptides, macrocycles, oligonucleotides and conjugates thereof.

Organization Christian Heinis

Accessibility Informed public

Admittance Free